Metraipolis › archive › dc_692b27303d64

Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging… — Europe PMC PMID:41228310

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41228310
DOI
10.3390/cancers17213520
License (as archived)
solo-consultazione
Archived
2026-11-08T21:49:26.032Z
SHA-256 of the archived text
6943a808a2fdb568b42cc8314d85e79f2c18c4b985b7226c80396e5ea64f7d6e
Stable URL of this page
https://metraipolis.com/documento/dc_692b27303d64

How to cite

Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging… — Europe PMC PMID:41228310 — Europe PMC (en), https://europepmc.org/article/MED/41228310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_692b27303d64 (Metraipolis archive dc_692b27303d64, sha256 6943a808a2fdb568b42cc8314d85e79f2c18c4b985b7226c80396e5ea64f7d6e)
BibTeX
@misc{dc692b27303d64,
  title = {Impact of Anti-HER2 Therapies on Overall Survival in Patients with HER2-Positive Metastatic Breast Cancer: Focusing on Intracranial Efficacy of Emerging… — Europe PMC PMID:41228310},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41228310},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_692b27303d64; sha256 6943a808a2fdb568b42cc8314d85e79f2c18c4b985b7226c80396e5ea64f7d6e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41228310. Agents can read the archived copy with the MCP tool read_document.